HEPA
Price:
$0.5817
Market Cap:
$3.37M
Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It is involved in developing Rencofilstat, a cyclophilin inhibitor that has completed Phase 2a clinical trials to target multiple pathologic pathways involved in the progression of liver disease; and is in clinical-phase development for the treatment of non-alcoholic steatohepatitis (NASH), as well as in nonclinical studies to reduce liver fibrosis and hepatocellular carcinoma tumor burden in experimental models of NASH, and has demonstrated antiviral activities towards hepatitis B, C, and D viruses through several mechanisms. The co...[Read more]
Industry
Biotechnology
IPO Date
2014-02-10
Stock Exchange
NASDAQ
Ticker
HEPA
According to Hepion Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.09. This represents a change of -83.88% compared to the average of -0.56 of the last 4 quarters.
The mean historical PE Ratio of Hepion Pharmaceuticals, Inc. over the last ten years is -1.97. The current -0.09 PE Ratio has changed 356.45% with respect to the historical average. Over the past ten years (40 quarters), HEPA's PE Ratio was at its highest in in the June 2015 quarter at 0. The PE Ratio was at its lowest in in the September 2018 quarter at -12.68.
Average
-1.97
Median
-1.61
Minimum
-7.70
Maximum
-0.26
Discovering the peaks and valleys of Hepion Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 305.17%
Maximum Annual PE Ratio = -0.26
Minimum Annual Increase = -79.30%
Minimum Annual PE Ratio = -7.70
Year | PE Ratio | Change |
---|---|---|
2023 | -0.26 | -51.49% |
2022 | -0.54 | -77.87% |
2021 | -2.45 | 135.18% |
2020 | -1.04 | -33.09% |
2019 | -1.56 | 305.17% |
2018 | -0.38 | -79.30% |
2017 | -1.86 | -18.27% |
2017 | -2.27 | 37.13% |
2016 | -1.66 | -78.50% |
2015 | -7.70 | 185.94% |
The current PE Ratio of Hepion Pharmaceuticals, Inc. (HEPA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-1.08
5-year avg
-1.17
10-year avg
-1.97
Hepion Pharmaceuticals, Inc.’s PE Ratio is greater than Enveric Biosciences, Inc. (-0.30), greater than CohBar, Inc. (-0.12), greater than Elevation Oncology, Inc. (-0.76), greater than Ocean Biomedical, Inc. (-0.89), less than AVROBIO, Inc. (2.07), greater than Zura Bio Limited (-10.10), less than eFFECTOR Therapeutics, Inc. (-0.00),
Company | PE Ratio | Market cap |
---|---|---|
-0.30 | $3.75M | |
-0.12 | $1.42M | |
-0.76 | $30.29M | |
-0.89 | $31.57M | |
2.07 | $5.24M | |
-10.10 | $258.92M | |
-0.00 | $118.08K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hepion Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hepion Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Hepion Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Hepion Pharmaceuticals, Inc. (HEPA)?
What is the highest PE Ratio for Hepion Pharmaceuticals, Inc. (HEPA)?
What is the 3-year average PE Ratio for Hepion Pharmaceuticals, Inc. (HEPA)?
What is the 5-year average PE Ratio for Hepion Pharmaceuticals, Inc. (HEPA)?
How does the current PE Ratio for Hepion Pharmaceuticals, Inc. (HEPA) compare to its historical average?